SCHEMBL2645657

SCHEMBL2645657

[O]c1cccc(C=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103249305-A Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms INSPIRE PHARMACEUTICALS INC 2013-08-14 CN disclosed
EP-1702919-B1 NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE MSD KK (JP) 2012-05-30 EP disclosed
CN-102442941-A Polycyclic acid compounds useful as crth2 antagonists and antiallergic agents ASTELLAS PHARMA INC 2012-05-09 CN disclosed
CN-101175724-B pyrrolidine derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2011-12-07 CN disclosed
US-7728025-B2 2-heteroaryl-substituted benzimidazole derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2010-06-01 US disclosed
CN-101636386-A Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents ASTELLAS PHARMA INC 2010-01-27 CN disclosed
CN-101175724-A Pyrrolidine derivative or salt thereof ASTELLAS PHARMA INC (JP) 2008-05-07 CN disclosed
CN-100383138-C N-monoacetyl o-phenylenediamines, their fused heterocyclic derivatives and their use as medicaments HOFFMANN LA ROCHE (CH) 2008-04-23 CN disclosed
US-20080070928-A1 Novel 2-Heteroaryl-Substituted Benzimidazole Derivative MSD K.K. (JP) 2008-03-20 US disclosed
EP-1702919-A1 NOVEL 2-HETEROARYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-09-20 EP disclosed
CN-1747948-A Novel n-monoacylated o-phenylenediamines, their condensed heterocyclic derivatives and their use as pharmaceutical agents HOFFMANN LA ROCHE (CH) 2006-03-15 CN disclosed
EP-1585517-A1 USE OF SUBSTITUTED 2-PHENYLBENZIMIDAZOLES AS MEDICAMENTS Boehringer Ingelheim International GmbH (DE) 2005-10-19 EP disclosed
WO-2004062663-A1 USE OF SUBSTITUTED 2-PHENYLBENZIMIDAZOLES AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2004-07-29 WO disclosed
US-6627714-B2 Copolymerizing ethylene and dicyclopentadiene or tricyclopentadiene, and cyclic olefin in presence of metallocene catalyst to produce copolymer MARUZEN PETROCHEMICAL CO., LTD. (JP) 2003-09-30 US disclosed
US-20020058767-A1 Method for producing an olefin type copolymer having a cyclic structure MARUZEN PETROCHEMICAL CO., LTD. (JP) 2002-05-16 US disclosed
EP-1205497-A2 Method for producing an olefin type copolymer having a cyclic structure MARUZEN PETROCHEMICAL CO., LTD. (JP) 2002-05-15 EP disclosed
CN-1282340-A Solid catalysts for polymerization of olefins and process for production of olefin polymers therewith MARUZEN PETROCHEM CO LTD (JP) 2001-01-31 CN disclosed
EP-0808319-A1 EPIPODOPHYLLOTOXIN TRIARYLOXYACETYL DERIVATIVES, METHOD FOR PREPARING SAME, AND USE OF SAID DERIVATIVES AS CANCER DRUGS PIERRE FABRE MEDICAMENT (FR) 1997-11-26 EP disclosed
WO-1996024602-A1 EPIPODOPHYLLOTOXIN TRIARYLOXYACETYL DERIVATIVES, METHOD FOR PREPARING SAME, AND USE OF SAID DERIVATIVES AS CANCER DRUGS PIERRE FABRE MEDICAMENT (FR) 1996-08-15 WO disclosed